Assembly Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €83.76M +127.3% -€20.84M -52.0% -24.9% +0.93 pp €86.39M -1,026.9% 103.1% +1.3 pp
    (estimated) €36.85M -41.2% -€43.43M +196.0% -117.8% -0.94 pp -€9.32M -124.5% -25.3% -0.86 pp
    (estimated) €62.69M +220.1% -€14.67M -71.8% -23.4% +2.4 pp €38.06M -164.9% 60.7% +3.6 pp
    (estimated) €19.58M -33.2% -€52.10M +41.7% -266.1% -1.4 pp -€58.69M -8.8% -299.7% -0.80 pp
    (estimated) €29.31M +19.1% -€36.76M +6.0% -125.4% +0.15 pp -€64.38M +46.0% -219.7% -0.41 pp
    €24.61M +298.2% -€34.67M -34.4% -140.9% +7.1 pp -€44.09M -322.1% -179.1% -5.0 pp
    €6.18M +∞% -€52.84M -33.5% -854.8% -8.5 pp €19.85M -127.3% 321.1% +3.2 pp
    €0.00 -100.0% -€79.46M -29.1% N/A -€72.81M -6.6% N/A
    €5.40M -92.1% -€112.07M +118.1% -2,076.4% -20 pp -€77.93M +48.7% -1,443.9% -14 pp
    €68.27M +395.6% -€51.37M -39.0% -75.3% +5.4 pp -€52.42M -26.4% -76.8% +4.4 pp
    €13.78M +7.8% -€84.26M +7.6% -611.6% +0.014 pp -€71.21M +27.7% -516.9% -0.80 pp
    €12.78M +64.1% -€78.32M +112.0% -613.0% -1.4 pp -€55.77M -2,471.6% -436.5% -4.7 pp
    €7.78M +∞% -€36.95M -3.3% -474.7% -4.7 pp €2.35M -107.8% 30.2% +0.30 pp
    €0.00 +NaN% -€38.20M +55.6% N/A -€29.98M +86.4% N/A
    €0.00 +NaN% -€24.56M +19.6% N/A -€16.09M +25.7% N/A
    €0.00 +NaN% -€20.53M +22.6% N/A -€12.79M -16.7% N/A
    €0.00 +NaN% -€16.75M -21.7% N/A -€15.35M -16.8% N/A
    €0.00 +NaN% -€21.40M -27.8% N/A -€18.45M -14.7% N/A
    €0.00 +NaN% -€29.64M +124.6% N/A -€21.62M +380.5% N/A
    €0.00 +NaN% -€13.20M +236.8% N/A -€4.50M +49.8% N/A
    €0.00 +NaN% -€3.92M -48.3% N/A -€3.00M -16.0% N/A
    €0.00 -€7.58M N/A -€3.58M N/A

    Notifications